Publication | Closed Access

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Hematological MalignancyLymphoid Neoplasia6-Year ResultsMabthera International TrialMedicineImmunologyPathologyChop-like ChemotherapyImmunotherapyOncologyRadiation OncologyCancer Research